These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 20481647)

  • 1. Impact of antiretroviral therapy on growth, body composition and metabolism in pediatric HIV patients.
    Kim RJ; Rutstein RM
    Paediatr Drugs; 2010 Jun; 12(3):187-99. PubMed ID: 20481647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial impact of human immunodeficiency virus and antiretrovirals on infected pediatric patients with or without lipodystrophy.
    Morén C; Noguera-Julian A; Rovira N; Corrales E; Garrabou G; Hernández S; Nicolás M; Tobías E; Cardellach F; Miró O; Fortuny C
    Pediatr Infect Dis J; 2011 Nov; 30(11):992-5. PubMed ID: 21697766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipodystrophy, insulin resistance, diabetes mellitus, dyslipidemia, and cardiovascular disease in human immunodeficiency virus infection.
    Tanwani LK; Mokshagundam SL
    South Med J; 2003 Feb; 96(2):180-8; quiz 189. PubMed ID: 12630645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic and body composition effects of newer antiretrovirals in HIV-infected patients.
    Srinivasa S; Grinspoon SK
    Eur J Endocrinol; 2014 May; 170(5):R185-202. PubMed ID: 24523497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of rosiglitazone on insulin sensitivity, beta cell function, bone mineral density, and body composition in hiv-positive patients on highly-active antiretroviral therapy (HAART).
    Schindler K; Rieger A; Tura A; Gmeinhardt B; Touzeau-Römer V; Haider D; Pacini G; Ludvik B
    Horm Metab Res; 2009 Jul; 41(7):573-9. PubMed ID: 19322744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. San Diego, California, USA 22-25 September 2002.
    Nolan D; Christiansen F
    Expert Opin Drug Saf; 2003 Jan; 2(1):95-101. PubMed ID: 12904128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy.
    Blümer RM; van Vonderen MG; Sutinen J; Hassink E; Ackermans M; van Agtmael MA; Yki-Jarvinen H; Danner SA; Reiss P; Sauerwein HP
    AIDS; 2008 Jan; 22(2):227-36. PubMed ID: 18097225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities in body composition and nutritional status in HIV-infected children and adolescents on antiretroviral therapy.
    Ramalho LC; Gonçalves EM; de Carvalho WR; Guerra-Junior G; Centeville M; Aoki FH; Morcillo AM; dos Santos Vilela MM; da Silva MT
    Int J STD AIDS; 2011 Aug; 22(8):453-6. PubMed ID: 21795418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body composition and metabolic changes in HIV-infected patients.
    Stanley TL; Grinspoon SK
    J Infect Dis; 2012 Jun; 205 Suppl 3(Suppl 3):S383-90. PubMed ID: 22577212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial markers and HIV infection in the era of highly active antiretroviral treatment.
    de Larrañaga GF; Bocassi AR; Puga LM; Alonso BS; Benetucci JA
    Thromb Res; 2003 May; 110(2-3):93-8. PubMed ID: 12893023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic complications of antiretroviral therapy in children.
    Leonard EG; McComsey GA
    Pediatr Infect Dis J; 2003 Jan; 22(1):77-84. PubMed ID: 12544413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-traditional adipokines in pediatric HIV-related lipodystrophy: a-FABP as a biomarker of central fat accumulation.
    Theodoridou K; Margeli A; Spoulou V; Bathrellou I; Skevaki C; Chrousos GP; Papassotiriou I; Kanaka-Gantenbein C
    Scand J Clin Lab Invest; 2014 Jan; 74(1):67-73. PubMed ID: 24266781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipodystrophy syndrome: the morphologic and metabolic effects of antiretroviral therapy in HIV infection.
    Norris A; Dreher HM
    J Assoc Nurses AIDS Care; 2004; 15(6):46-64. PubMed ID: 15538016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioelectrical impedance analysis in HIV-infected patients treated with triple antiretroviral treatment.
    Schwenk A; Beisenherz A; Kremer G; Diehl V; Salzberger B; Fätkenheuer G
    Am J Clin Nutr; 1999 Nov; 70(5):867-73. PubMed ID: 10539747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of long-term antiretroviral therapy in HIV-infected children.
    Prendergast AJ
    Arch Dis Child; 2013 Apr; 98(4):245-6. PubMed ID: 23413313
    [No Abstract]   [Full Text] [Related]  

  • 16. [Abnormal body fat distribution and type of antiretroviral therapy as predictors of cardiovascular disease risk in HIV-infected patients].
    Ena J; Benito C; Llácer P; Pasquau F; Amador C
    Med Clin (Barc); 2004 May; 122(19):721-6. PubMed ID: 15171905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations.
    Gougeon ML; Pénicaud L; Fromenty B; Leclercq P; Viard JP; Capeau J
    Antivir Ther; 2004 Apr; 9(2):161-77. PubMed ID: 15134178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy.
    Falutz J
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):651-61. PubMed ID: 17710086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV infection--a risk factor for osteoporosis.
    Thomas J; Doherty SM
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):281-91. PubMed ID: 12843738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What does the term "HIV-associated lipodystrophy" mean?
    Marcason W
    J Am Diet Assoc; 2009 Feb; 109(2):364. PubMed ID: 19167963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.